Paul Campbell
Interim Chief Financial Officer, Chief Accounting Officer and Corporate ControllerViatris
PharmaceuticalsView Profile →Executive Vice President, Finance and Chief Financial Officer · Regeneron Pharmaceuticals
Chris Fenimore is executive vice president of finance and chief financial officer of Regeneron Pharmaceuticals. He became CFO in February 2024 after a career in financial planning and controllership at the company, which he joined in 2003.
Last reviewed: Oct 21, 2026
Executive Vice President, Finance and Chief Financial Officer Regeneron Pharmaceuticals
Last Reviewed: October 21, 2026
Chris Fenimore is executive vice president of finance and chief financial officer of Regeneron Pharmaceuticals. He became CFO in February 2024 after a career in financial planning and controllership at the company, which he joined in 2003.
Fenimore began his career as an auditor at KPMG. He subsequently worked in health care-focused venture capital and investment banking and served as vice president of Finance at Mojave Therapeutics before joining Regeneron in 2003.
His Regeneron career developed through financial planning and accounting. SEC disclosures identify him as vice president of Financial Planning from 2012 through 2016, deputy controller in early 2017, and vice president and controller from March 2017 through 2020. He became senior vice president and controller in January 2021.
In February 2024, he succeeded Robert Landry as CFO, initially with the senior vice president title. He advanced to executive vice president in January 2025. The current role places his finance experience across planning, reporting and controls within the company’s executive leadership.
The company’s current biography and 2026 proxy agree on his financial leadership and professional background. His Certified Public Accountant credential is in New York; no registration number or broader licensing claim is inferred.
Fenimore holds an MA in biotechnology from Columbia University, an MBA in professional accounting from Rutgers Business School and a BA in economics from Rutgers University.